Salicylic Acid
Hydrolyzed metabolite of aspirin; contributes most COX inhibition after the initial platelet acetylation event. Also a direct topical keratolytic.
Pharmacokinetic model
A route-level PK model for salicylic acid is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- NSAID active/metabolite
- Half-life
- 3 h
- Reference dose range
- 1–8 mg (single dose)
- Suggested cadence
- custom (shown daily)
- Validated against
- 1k mg oral — Cmax 65 mg/L at 1 h
Documented interactions
-
moderate
5-Aminosalicylic Acid (Mesalamine) + Salicylic Acid
5-Aminosalicylic Acid (Mesalamine) and Salicylic Acid both push the cox1 and cox2 in the same direction.
-
moderate
Aspirin (Acetylsalicylic Acid) + Salicylic Acid
Aspirin (Acetylsalicylic Acid) and Salicylic Acid both push the cox1 and cox2 in the same direction.
-
moderate
Celecoxib (Celebrex) + Salicylic Acid
Celecoxib (Celebrex) and Salicylic Acid both push the cox1 and cox2 in the same direction.
-
moderate
Diclofenac (Voltaren) + Salicylic Acid
Diclofenac (Voltaren) and Salicylic Acid both push the cox1 and cox2 in the same direction.
-
moderate
Meloxicam (Mobic) + Salicylic Acid
Meloxicam (Mobic) and Salicylic Acid both push the cox1 and cox2 in the same direction.
-
moderate
Mesalamine / 5-ASA (Lialda/Apriso/Pentasa) + Salicylic Acid
Mesalamine / 5-ASA (Lialda/Apriso/Pentasa) and Salicylic Acid both push the cox1 and cox2 in the same direction.
Serum checks 11 modeled interaction pairings for salicylic acid across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.